Skip to main content

Table 2 Study results magnetic resonance imaging (MRI) data

From: Noninvasive assessment and quantification of tumour vascularisation using MRI and CT in a tumour model with modifiable angiogenesis – An animal experimental prospective cohort study

 

H1299

A549

All tumours

Non-co-transplanted

Co-transplanted

p value

Non-co-transplanted

Co-transplanted

p value

Non-co-transplanted

Co-transplanted

p value

Tumour volume T2

[cm3]

1.6 (2.4)

3.8 (4.8)

0.001

0.2 (0.3)

4.4 (6.5)

0.000

0.2 (1.7)

4.0 (5.2)

<0.001

TOF

Numeric scale

1.3 ± 0.1

1.7 ± 0.1

0.009

1.2 ± 0.1

1.4 ± 0.1

0.009

1.2 ± 0.1

1.5 ± 0.1

0.006

Maximal ADCdiff

[mm2/s × 10−6]

1473 (616)

1672 (597)

0.047

1206 (396)

1714 (674)

0.005

1320 (441)

1695 (546)

<0.001

Minimal ADCdiff

[mm2/s × 10−6]

311 (385)

149 (77)

<0.001

348 (199)

173 (135)

<0.001

346 (224)

166 (97)

<0.001

Maximal ADCperf

[mm2/s × 10−6]

1712 (830)

2994 (305)

<0.001

1612 (614)

2999 (657)

<0.001

1616 (661)

2999 (476)

<0.001

Mean ADCperf

[mm2/s × 10−6]

568 (149)

722 (106)

0.001

646 (262)

723 (184)

0.203

636 (208)

723 (144)

0.005

  1. In vivo MRI quantitative results of T2 volumetry, time-of-flight (TOF) and apparent diffusion coefficient (ADC). First and second column show results separated for both cell lines, third column tumour cell lines merged together. Median (interquartile range); TOF: mean ± SD